MAYWOOD, Ill. -- New rankings show the Department of Molecular Pharmacology and Therapeutics of Loyola University Chicago Stritch School of Medicine ranks third in the country in the number of scientific publications per faculty member.
On average, Loyola faculty members published 3.49 research papers per year in peer-reviewed journals from 2000 to 2006. That's the third-highest average among 116 pharmacology and toxicology departments, according to The National Research Council's 2010 rankings of research doctorate programs.
Loyola's PhD program in Pharmacology and Therapeutics ranked 24th out of 116 programs. It ranked higher than any other pharmacology graduate program in Illinois, Wisconsin, Indiana and Iowa. It also ranked higher than the University of Michigan. Loyola was fourth in the number of students who received extramural fellowship funding. In research activity, Loyola ranked higher than other major institutions such as Boston University, University of Wisconsin, Case Western, Georgetown, Penn State and Cornell.
âThese rankings are a reflection of our faculty's hard work and dedication to graduate education, as well as their cutting-edge research," said department Chairman Tarun B. Patel, PhD.
Pharmacology research incorporates knowledge from all fields of biomedical research. Pharmacologists at Loyola study the molecular mechanisms of action of drugs, neurotransmitters, hormones and viruses to identify targets for therapeutic intervention in diseases.
Loyola's Department of Molecular Pharmacology and Therapeutics offers degrees leading to PhD, MS, MD/PhD and MS/MBA. Faculty research interests include neuroscience, cardiovascular biology, hematology and oncology. Research ranges from test-tube studies with recombinant proteins to epidemiological studies of human subjects.